Peculiarities of vitamin D metabolism in diabetic kidney disease

Authors

V.M. Yerokhovych Bogomolets National Medical University, Kyiv, Ukraine https://orcid.org/0000-0002-9800-9796
O.V. Karpenko Bogomolets National Medical University, Kyiv, Ukraine https://orcid.org/0000-0001-8952-8482
I.A. Paliienko Bogomolets National Medical University, Kyiv, Ukraine https://orcid.org/0000-0001-9939-7316
I.V. Dumka Bogomolets National Medical University, Kyiv, Ukraine https://orcid.org/0000-0002-6482-985X
O.A. Rudenko Bogomolets National Medical University, Kyiv, Ukraine https://orcid.org/0009-0004-3132-4689
Iu.I. Komisarenko Bogomolets National Medical University, Kyiv, Ukraine https://orcid.org/0000-0001-9912-4879

DOI:

https://doi.org/10.22141/2307-1257.13.4.2024.481

Keywords:

vitamin D, diabetic kidney disease, vitamin D binding protein, sodium-dependent glucose cotransporter-2 inhibitors

Abstract

The analysis of literature revealed the peculiarities of vitamin D metabolism in diabetic kidney damage, as well as its role in the development of renal, metabolic changes, including bone and mineral disorders. Vitamin D, due to its influence on various physiological processes through vitamin D receptors, plays a key role in the regulation of mineral and bone metabolism, the functioning of the immune system and the control of other extraskeletal effects. In patients with diabetic kidney damage, vitamin D deficiency causes impaired hydroxylation and the formation of an active metabolite (1,25(OH)2D3), which leads to the progression of kidney damage, the development of proteinuria and fibrosis. The mechanisms of glucose and vitamin D interaction at the level of the proximal tubules were analyzed, which emphasizes the need for further research to develop therapeutic strategies for correcting vitamin D deficiency in patients with diabetic kidney damage in order to improve their prognosis.

Downloads

Download data is not yet available.

References

Bikle DD. Vitamin D: an ancient hormone. Exp Dermatol. 2011 Jan;20(1):7-13. doi: 10.1111/j.1600-0625.2010.01202.x.

Hanel A, Carlberg C. Vitamin D and evolution: Pharmacologic implications. Biochem Pharmacol. 2020 Mar;173:113595. doi: 10.1016/j.bcp.2019.07.024.

Carlberg C. Vitamin D in the Context of Evolution. Nutrients. 2022 Jul 22;14(15):3018. doi: 10.3390/nu14153018.

Silva ICJ, Lazaretti-Castro M. Vitamin D metabolism and extraskeletal outcomes: an update. Arch Endocrinol Metab. 2022 Nov 11;66(5):748-755. doi: 10.20945/2359-3997000000565.

Janubová M, Žitňanová I. The effects of vitamin D on different types of cells. Steroids. 2024 Feb;202:109350. doi: 10.1016/j.steroids.2023.109350.

Nardin M, Verdoia M, Nardin S, et al. Vitamin D and Cardiovascular Diseases: From Physiology to Pathophysiology and Outcomes. Biomedicines. 2024 Mar 30;12(4):768. doi: 10.3390/biomedicines12040768.

Carlberg C, Velleuer E. Vitamin D and the risk for cancer: A molecular analysis. Biochem Pharmacol. 2022 Feb;196:114735. doi: 10.1016/j.bcp.2021.114735.

Sîrbe C, Rednic S, Grama A, Pop TL. An Update on the Effects of Vitamin D on the Immune System and Autoimmune Diseases. Int J Mol Sci. 2022 Aug 29;23(17):9784. doi: 10.3390/ijms23179784.

Roy NM, Al-Harthi L, Sampat N, et al. Impact of vitamin D on neurocognitive function in dementia, depression, schizophrenia and ADHD. Front Biosci (Landmark Ed). 2021 Jan 1;26(3):566-611. doi: 10.2741/4908.

Carlberg C. Vitamin D and Its Target Genes. Nutrients. 2022 Mar 24;14(7):1354. doi: 10.3390/nu14071354.

Yang S, Li A, Wang J, et al. Vitamin D Receptor: A Novel Therapeutic Target for Kidney Diseases. Curr Med Chem. 2018;25(27):3256-3271. doi: 10.2174/0929867325666180214122352.

Delrue C, Speeckaert MM. Vitamin D and Vitamin D-Binding Protein in Health and Disease. Int J Mol Sci. 2023 Feb 28;24(5):4642. doi: 10.3390/ijms24054642.

Kotsa K, Grammatiki M. The Role of Vitamin D in the Prevention and Treatment of Diabetes Mellitus. In: Watson RR, Preedy VR, editors. Bioactive Food as Dietary Interventions for Diabetes. 2nd ed. Cambridge, MA: Academic press; 2019 . 157-174 pp. doi: 10.1016/B978-0-12-813822-9.00010-2.

Nakhoul N, Thawko T, Farber E, et al. The Therapeutic Effect of Active Vitamin D Supplementation in Preventing the Progression of Diabetic Nephropathy in a Diabetic Mouse Model. J Diabetes Res. 2020 Nov 26;2020:7907605. doi: 10.1155/2020/7907605.

Lei M, Liu Z, Guo J. The Emerging Role of Vitamin D and Vitamin D Receptor in Diabetic Nephropathy. Biomed Res Int. 2020 Jul 11;2020:4137268. doi: 10.1155/2020/4137268.

Lytvyn Y, Bjornstad P, van Raalte DH, Heerspink HL, Cherney DZI. The New Biology of Diabetic Kidney Disease-Mechanisms and Therapeutic Implications. Endocr Rev. 2020 Apr 1;41(2):202-231. doi: 10.1210/endrev/bnz010.

Yerokhovych V, Karpenko O, Paliienko I, et al . Early diagnosis of mineral and bone disorders in patients with diabetic kidney disease on the background of type 2 diabetes. Mìžnarodnij endokrinologìčnij žurnal. 2024;20(4):238 -243. doi: 10.22141/2224-0721.20.4.2024.1400.

Sacerdote A, Dave P, Lokshin V, Bahtiyar G. Type 2 Diabetes Mellitus, Insulin Resistance, and Vitamin D. Curr Diab Rep. 2019 Sep 10;19(10):101. doi: 10.1007/s11892-019-1201-y.

Nordheim E, Geir Jenssen T. Chronic kidney disease in patients with diabetes mellitus. Endocr Connect. 2021 Apr 29;10(5):R151-R159. doi: 10.1530/EC-21-0097.

Watanabe K, Sato E, Mishima E, Miyazaki M, Tanaka T. What's New in the Molecular Mechanisms of Diabetic Kidney Disease: Recent Advances. Int J Mol Sci. 2022 Dec 29;24(1):570. doi: 10.3390/ijms24010570.

Delrue C, Speeckaert R, Delanghe JR, Speeckaert MM. The Role of Vitamin D in Diabetic Nephropathy: A Translational Approach. Int J Mol Sci. 2022 Jan 12;23(2):807. doi: 10.3390/ijms23020807.

Galuška D, Pácal L, Kaňková K. Pathophysiological Implication of Vitamin D in Diabetic Kidney Disease. Kidney Blood Press Res. 2021;46(2):152-161. doi: 10.1159/000514286.

Shi L, Xiao C, Zhang Y, et al. Vitamin D/vitamin D receptor/Atg16L1 axis maintains podocyte autophagy and survival in diabetic kidney disease. Ren Fail. 2022 Dec;44(1):694-705. doi: 10.1080/0886022X.2022.2063744.

Ding Y, Wu Q. 1,25D/VDR inhibits pancreatic β cell ferroptosis by downregulating FOXO1 expression in diabetes mellitus. Cell Signal. 2023 May;105:110564. doi: 10.1016/j.cellsig.2022.110564.

Gao J, Song X, Ou H, et al. The association between vitamin D and the progression of diabetic nephropathy: insights into potential mechanisms. Front Med (Lausanne). 2024 Jun 24;11:1388074. doi: 10.3389/fmed.2024.1388074.

Milder TY, Stocker SL, Samocha-Bonet D, Day RO, Greenfield JR. Sodium-glucose cotransporter 2 inhibitors for type 2 diabetes-cardiovascular and renal benefits in patients with chronic kidney disease. Eur J Clin Pharmacol. 2019 Nov;75(11):1481-1490. doi: 10.1007/s00228-019-02732-y.

De Jong MA, Petrykiv SI, Laverman GD, et al. Effects of Dapagliflozin on Circulating Markers of Phosphate Homeostasis. Clin J Am Soc Nephrol. 2019 Jan 7;14(1):66-73. doi: 10.2215/CJN.04530418.

Perkovic V, Jardine MJ, Neal B, et al.; CREDENCE Trial Investigators. Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy. N Engl J Med. 2019 Jun 13;380(24):2295-2306. doi: 10.1056/NEJMoa1811744.

Blau JE, Bauman V, Conway EM, et al. Canagliflozin triggers the FGF23/1,25-dihydroxyvitamin D/PTH axis in healthy volunteers in a randomized crossover study. JCI Insight. 2018 Apr 19;3(8):e99123. doi: 10.1172/jci.insight.99123.

Pazianas M, Miller PD. Osteoporosis and Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD): Back to Basics. Am J Kidney Dis. 2021 Oct;78(4):582-589. doi: 10.1053/j.ajkd.2020.12.024.

Downloads

PDF (Українська)

Published

2025-01-09

How to Cite

Yerokhovych, V., Karpenko, O., Paliienko, I., Dumka, I., Rudenko, O., & Komisarenko, I. (2025). Peculiarities of vitamin D metabolism in diabetic kidney disease. KIDNEYS, 13(4), 257–260. https://doi.org/10.22141/2307-1257.13.4.2024.481

Download Citation

Issue

Vol. 13 No. 4 (2024)

Section

Reviews

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.